• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BACTEC¿ MGIT¿ 960 SUPPLEMENT KIT; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BACTEC¿ MGIT¿ 960 SUPPLEMENT KIT; SYSTEM, BLOOD CULTURING Back to Search Results
Model Number 245124
Device Problem Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/05/2023
Event Type  malfunction  
Manufacturer Narrative
Investigaion summary mgit 960 supplement kit batch 2181266 is composed of mgit panta batch 2181202 and mgit 960 growth supplement batch 2181253.The batch history record review for mgit 960 supplement kit batch 2181266 was satisfactory.No quality notifications were generated during manufacturing and no other complaints have been taken on this kit batch.Mgit panta is manufactured by rehydrating components in usp purified water and mixed into a homogenous solution.The solution is then sterile filtered, dispensed into vials, and stoppered by machine.The vials are lyophilized and crimp caps are applied per standard operating procedures (sop).Mgit 960 growth supplement is manufactured by rehydrating the media components with usp purified water and mixed until a homogeneous solution is obtained.The solution is then sterile filtered and dispensed into vials; stoppers are manually placed in the vial opening; septum caps are manually placed on top of the stopper and then mechanically crimped per sop.Six mgit panta vials are then manually packaged with six mgit growth supplement vials to make a mgit 960 supplement kit (material 245124).The batch history record reviews for mgit panta batch 2181202 and mgit 960 growth supplement batch 2181253 were satisfactory and no notifications were generated during manufacturing.Qc inspection and testing were satisfactory at time of release.Retentions for panta batch 2181202 (10 vials) were available for inspection and growth supplement batch 2181253 (7 vials) were available for inspection.All 17/17 retention vials were in good condition and there was no evidence of contamination in 17/17 retention vials.For further investigation, two crimp, capped, and sealed growth supplement vials were incubated.One supplement vial was placed into 20-25-degree celsius incubation and one supplement vial was placed into 33-37-degree celsius incubation.For additional testing, two panta vials from batch 2181202 were reconstituted with two growth supplement vials from batch 2181253.One panta reconstituted with supplement was placed into the 20-25-degree celsius incubator and one reconstituted panta with supplement was placed into the 33-37-degree celsius incubator.The remaining supplement in both supplement vials that were used to reconstitute the panta were also incubated.One vial was placed into the 20-25-degree celsius incubator and one vial was placed into the 33-37-degree celsius incubator.At the end of a seven-day incubation period, no microbial growth was observed in 6/6 incubated retention vials.No photos were received to assist with the investigation.No returns were received to assist with the investigation.The complaint cannot be confirmed based on the retention investigation.Bd will continue to trend complaints for contamination/foreign material.
 
Event Description
It was reported that while using the bd bactec¿ mgit¿ 960 supplement kit that there was contamination.The following information was provided by the initial reporter: this is a report about foreign matter.The customer found foreign matter resembling mold in the supplement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BACTEC¿ MGIT¿ 960 SUPPLEMENT KIT
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key16493089
MDR Text Key310967554
Report Number1119779-2023-00234
Device Sequence Number1
Product Code MDB
UDI-Device Identifier00382902451242
UDI-Public00382902451242
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K974883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/24/2023
Device Model Number245124
Device Catalogue Number245124
Device Lot Number2181266
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/06/2023
Initial Date FDA Received03/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/30/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-